MedMira Inc

NEW
OTCPK:MMIRF (Canada)  
$ 0.049 +0.037 (+302.48%) 10:08 PM EST
At Loss
Market Cap:
$ 34.50M
Enterprise V:
$ 41.31M
Volume:
0
Avg Vol (2M):
10.41K
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
10.41K

Business Description

Description
MedMira Inc is a biotechnology company engaged in the research, development, and manufacturing of rapid diagnostics and technologies. The company operates in one reportable operating segment, rapid diagnostic products and services. Its product line includes HIV, COVID-19, syphilis, Multiplex, Miriad RVF Toolkit, and H. pylori. The company generates revenue from North America, Europe, and other regions, with the majority generated from North America.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt
0.01
Equity-to-Asset
-6.72
Debt-to-Equity
-0.41
Debt-to-EBITDA
-4.61
Piotroski F-Score
4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
-51.05
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
99.89
9-Day RSI
97.4
14-Day RSI
90.83
3-1 Month Momentum %
-73.11
6-1 Month Momentum %
-75.8
12-1 Month Momentum %
-77.59

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.07
Quick Ratio
0.06
Days Inventory
1401.6
Days Sales Outstanding
2561.57
Days Payable
19703.36

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-0.2
Shareholder Yield %
-1.53

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin %
70.9
Operating Margin %
-1287.83
Net Margin %
-1849.21
EBITDA Margin %
-1124.34
FCF Margin %
-1039.71
OCF Margin %
-1039.71
ROA %
-92.8
ROIC %
-14.94
3-Year ROIIC %
-37.97
ROC (Joel Greenblatt) %
-116.74
Moat Score
3
Tariff Resilience Score
5

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT
-22.73
EV-to-EBITDA
-26.03
EV-to-Revenue
292.64
EV-to-FCF
-28.2
Earnings Yield (Greenblatt) %
-4.4
FCF Yield %
-4.3